Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1995
12/06/1995EP0685481A2 Alkaloids from mappia foetida, the use thereof and formulations containing them
12/06/1995EP0685236A1 Prevention and treatment of retroviral disease
12/06/1995EP0685235A1 Extracts of piliostigma thonningii, the use thereof and formulations containing them
12/06/1995EP0685232A2 Cefixim formulation
12/06/1995EP0685160A1 Biocidal compositions
12/06/1995EP0685159A1 Biocidal compositions
12/06/1995EP0685158A1 Biocidal compositions
12/06/1995EP0684838A1 Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a
12/06/1995EP0684836A1 Combinations of retroviral inhibitors
12/06/1995EP0684821A1 Substituted azolone derivatives for treating diseases caused by helicobacter
12/06/1995EP0684818A1 Method of reversing resistance of hiv-1 strains to zidovudine
12/06/1995EP0610250B1 Porcine reproductive respiratory syndrome (prrs) vaccine and diagnostic
12/06/1995EP0409962B1 Agent for inhibiting hiv-proteases
12/06/1995CN1112928A Novel method for preparation and/or purification of clavulanic acid or pharmaceutical salt or ester of same
12/06/1995CN1112825A Minimizing trichomadesis with anti-fungus compound and halogeno-anti-bacteria compound
12/05/1995US5473071 Process for the preparation of fused pyridine compounds
12/05/1995US5473063 Reacting 2,3-epoxy-butanediol/1,4-/(having protected hydroxyl groups) with an alpha allylic nucleophile yields 2-hydroxy-3-allyl-1,4-butanediol, then oxidatively cleaving the double bond, cyclization, halogenation, acetylation or oxyalkylation
12/05/1995US5472976 Poly 4-aminopyrrole-2-carboxyamide derivatives, and pharmaceutical compositions which contain them
12/05/1995US5472965 Useful for treatment of retrovirus infections; less toxic
12/05/1995US5472857 DNA encoding canine granulocyte colony stimulating factor (G-CSF)
12/02/1995CA2127762A1 Extracts from piliostigma thonningii, the use thereof and formulations containing them
12/01/1995CA2150442A1 Cefixime composition
11/1995
11/30/1995WO1995032310A1 Identification and use of antiviral compounds
11/30/1995WO1995032302A1 Dna encoding glutamate gated chloride channels
11/30/1995WO1995032298A2 Safe vectors for gene therapy
11/30/1995WO1995032282A1 Interleukin-6 splice variant
11/30/1995WO1995032213A1 Oligonucleotides with anti-cytomegalovirus activity
11/30/1995WO1995032210A1 Cephalosporin compounds and processes for the preparation thereof
11/30/1995WO1995032200A1 Oxathiolanes, method for their preparation and pharmaceutical compositions containing same
11/30/1995WO1995032185A1 N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors
11/30/1995WO1995031987A1 Use of pteridine derivatives as no-synthase inhibitors
11/30/1995WO1995031985A2 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
11/30/1995WO1995031966A1 Antimicrobial oil-in-water emulsions
11/30/1995WO1995031956A1 Antibacterial oil-in-water emulsions
11/30/1995WO1995029239A3 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/30/1995WO1995027046A3 Enzymatic antimicrobial compositions containing haloperoxidases
11/30/1995DE4418096A1 Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase The use of pteridine derivatives as inhibitors of NO synthase
11/30/1995CA2191191A1 Oligonucleotides with anti-cytomegalovirus activity
11/30/1995CA2190606A1 Antimicrobial oil-in-water emulsions
11/30/1995CA2190604A1 Antibacterial oil-in-water emulsions
11/30/1995CA2190587A1 Identification and use of antiviral compounds
11/30/1995CA2190472A1 N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors
11/30/1995CA2190247A1 Safe vectors for gene therapy
11/30/1995CA2190245A1 Cephalosporin compounds and processes for the preparation thereof
11/30/1995CA2167930A1 Oxathiolanes, method for their preparation and pharmaceutical compositions containing same
11/29/1995EP0684253A1 Desalaninebenanomicin a derivative and production thereof
11/29/1995EP0684244A1 1,9-bridged thiazolo(3,2-a)quinoline derivatives
11/29/1995EP0684236A2 N-(2-Amino-4,6-dichloropyrimidin-5-yl)formamide and process for its production
11/29/1995EP0683816A1 Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
11/29/1995EP0683793A1 Vaccines and methods for preventing and treating fescue toxicosis in herbivores
11/29/1995EP0683784A1 7,42-bis (o-demethyl) rapamycin
11/29/1995EP0683783A1 Rapamycin derivative process for its preparation and its use
11/29/1995EP0683776A1 Substituted heteroarylalkylthiopyridines for controlling helicobacter bacteria
11/29/1995EP0683675A1 Human monoclonal antibodies to cytomegalovirus
11/29/1995CN1112558A Azoxycyanobenzodioxane derivatives
11/29/1995CN1112437A Medicine for treating phthisis and its preparation
11/28/1995US5470967 Oligonucleotide analogs with sulfamate linkages
11/28/1995US5470958 Antisera against a PEB1 antigen from Campylobacter jejuni
11/28/1995US5470843 Carbohydrate-containing polymers, their preparation and use
11/28/1995US5470835 Transfer factor and methods of use
11/28/1995US5470827 Method of producing iturin A and antifungal agent for profound mycosis
11/28/1995US5470734 Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
11/28/1995US5470702 HIV-2 transmembrane glycoprotein homodimer (gp 80)
11/28/1995CA2150093A1 1,9-bridged thiazolo[3,2-a]quinoline derivatives
11/28/1995CA2075521C Stabilized live vaccine
11/28/1995CA1337645C Teicoplanin-like derivatives
11/28/1995CA1337643C Method and microorganism for the production of faeriefungin
11/23/1995WO1995031565A1 Alphavirus expression vector
11/23/1995WO1995031555A1 Fusion glycoprotein from hcmv and hsv
11/23/1995WO1995031550A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins
11/23/1995WO1995031538A1 Human dna topoisomerase i-alpha
11/23/1995WO1995031532A1 Papillomavirus vaccines
11/23/1995WO1995031476A1 Recombinant papilloma virus l1
11/23/1995WO1995031468A1 Macrophage migration inhibitory factor-3
11/23/1995WO1995031467A1 Monocyte chemotactic protein-4
11/23/1995WO1995031429A1 Photocleavable agents and conjugates for the detection and isolation of biomolecules
11/23/1995WO1995031216A1 Vaccine against mycobacterial infections
11/23/1995WO1995031215A1 VACCINE FOR $i(MORAXELLA CATARRHALIS)
11/23/1995WO1995031213A1 IFN-β LIQUID FORMULATIONS
11/23/1995WO1995031198A1 Thiadiazoles and their use as antipicornaviral agents
11/23/1995WO1995031197A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/23/1995CA2190529A1 Fusion glycoprotein from hcmv and hsv
11/23/1995CA2190465A1 Ifn-.beta. liquid formulations
11/23/1995CA2190102A1 Human papilloma virus inhibition by a hairpin ribozyme
11/23/1995CA2189528A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/23/1995CA2188421A1 Alphavirus expression vector
11/22/1995EP0683173A1 Cyclic adhesion inhibitors
11/22/1995EP0683169A1 8-Amino-pyrido 1,2,3-de 1,3,4 benzoxadiazine derivatives, and antibacterial agents containing them
11/22/1995EP0682950A1 Mucosal administration of pneumococcal antigens
11/22/1995EP0682712A1 Human interferon expression vectors for treating aids
11/22/1995EP0682707A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion
11/22/1995EP0682667A1 2-phenanthridinyl carbapenem antibacterial agents
11/22/1995EP0682666A1 2-phenanthridinyl carbapenem antibacterial agents
11/22/1995EP0682663A1 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b]pyran-2-ones useful to treat retroviral infections
11/22/1995EP0682526A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS
11/22/1995EP0682524A1 Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant
11/22/1995EP0682523A1 Use of tricyclic isoindolinones as antiviral drugs, and new, optically active isoindolinones
11/22/1995EP0427788B1 Methods for isolating herpes virus thymidine kinase-encoding dna
11/22/1995CN1112356A Novel attenuated pseudomonas aeruginosa strains
11/22/1995CN1112125A Acyloxyhexanoic acid derivatives
1 ... 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 ... 1798